{"product_id":"taltz-ixekizumab-pluma-80mg-ml-c1","title":"Taltz (Ixekizumab) Pen 80Mg\/Ml C1","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eBiological Medicines\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eTaltz\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eLilly\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eIxekizumab\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003ePen 80 mg\/ml C1\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eLilly\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eTaltz (Ixekizumab) is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is also used in the treatment of psoriatic arthritis in adults, as well as in the treatment of ankylosing spondylitis in patients who have not responded adequately to other treatments. The efficacy of Taltz has been proven in clinical studies demonstrating a significant improvement in patients' quality of life by reducing the area and severity of skin lesions, as well as the signs and symptoms of joint diseases.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach Taltz pen contains 80 mg of Ixekizumab in a sterile solution. Additionally, it contains excipients such as sodium chloride, sodium phosphate, water for injection, among others, which facilitate the administration of the medication.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eThis medication is contraindicated in patients with known hypersensitivity to Ixekizumab or any of the formulation components. Its use is not recommended in patients with severe active infections or those with a history of recurrent infections.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eCaution should be exercised in patients with a history of tuberculosis, chronic infections, or those who are immunocompromised. Regular follow-up of patients is important to detect signs of infection and assess treatment tolerance. It is recommended to avoid live vaccinations while undergoing treatment with Taltz.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore refrigerated between 2°C and 8°C. Do not freeze. Keep out of reach of children. Do not use after the expiration date indicated on the package.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Lilly","offers":[{"title":"Default Title","offer_id":47148504940769,"sku":"7501082243444","price":43215.71,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/WeCare-Pharma-Producto_53f45729-0258-4dfc-a329-1d4a7180fd66.jpg?v=1757983309","url":"https:\/\/wecarepharma.mx\/en\/products\/taltz-ixekizumab-pluma-80mg-ml-c1","provider":"WeCare Pharma","version":"1.0","type":"link"}